A study on khanda Amalaki in Children suffering from recurrent Cough and cold

Efficacy of khanda Amalaki in management of Recurrent upper respiratory tract infection in children- a single arm clinical trial - NIL

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/05/111280

Enrollment

Registered

2026-05-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J069- Acute upper respiratory infection,unspecified Health Condition 2: J069- Acute upper respiratory infection,unspecified

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children aged between 02 to 10 years of irrespective of gender, religion, socio economic status and food habits. 2. Children with recurrent respiratory tract infections. (Respiratory infections are considered as recurrent from three episodes of infections during six months period).

Exclusion criteria

Exclusion criteria: 1. Children with major systemic illness requiring hospitalization. 2. Children with any congenital anomalies or birth defects or genetic disorder. 3. Children with co-morbidities like Tuberculosis, HIV. 4. Children with other chronic condition like Bronchial Asthma.

Design outcomes

Primary

Measure	Time frame
Improvement in Morbidity score. Improved Bala Assessment scoreTimepoint: Baseline and at the end of 3 months treatment	—

Secondary

Measure	Time frame
Changes in blood investigations: CBC, ESR, CRP quantitative, AEC, Total IgG, Total IgMTimepoint: Baseline and at the end of 3 months treatment	—

Countries

India

Contacts

Public ContactDr V K kori

Institute of teaching and research in ayurveda jamnagar

drvkkori@yahoo.co.in9409207285

Outcome results